D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
PEREZ JA and FARIAS CE [ETHIONAMIDE-CYCLOSERINE COMBINATION IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE USUAL DRUGS]. 1963 Sep-Dec Torax pmid:14158168
CETRANGOLO A [DETERMINATION OF THE RESISTANCE TO THE MINOR DRUGS]. 1963 Sep-Dec Torax pmid:14158174
CETRANGOLO A [TEST OF SERUM ACTIVITY]. 1963 Sep-Dec Torax pmid:14158175
PILHEU JA [BRONCHIAL TUBERCULOSIS AND BACTERIAL RESISTANCE]. 1963 Sep-Dec Torax pmid:14158177
LESTON JM [NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS]. 1963 Sep-Dec Torax pmid:14159777
DUBRA F [THERAPEUTIC PLAN]. 1963 Sep-Dec Torax pmid:14159778
Uçak D and Uçak A [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid]. 1969 Tip Fak Mecm pmid:5398987
Brinch L et al. [Hairy cell leukemia and Mycobacterium malmoense infection]. 1990 Tidsskr. Nor. Laegeforen. pmid:2321208
Ovreberg K [Treatment with secondary antitubercular agents]. 1968 Tidsskr. Nor. Laegeforen. pmid:4298856
Aspevik E [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis]. 1967 Tidsskr. Nor. Laegeforen. pmid:6047184
Abubakar I et al. Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. 2009 Thorax pmid:19318348
Schindel L [Clinically observed side effects of more recent antibiotics. Amphotericin-B-bacitracin-cycloserine-neomycin-novobiocin-polymyxin]. 1966 Ther Umsch pmid:4293912
DI STEFANO A and PALATRESI R [Use of endobronchial instillations of D-cycloserine in clinical treatment of tuberculoss]. 1960 Ther Umsch pmid:13722560
Protivinsky R [Tuberculostatics. 1]. 1968 Ther Ggw pmid:5753422
McKinney JD and Stammer CH Role of the azomethine in the dimerization of cycloserine by aldehydes. 1969 Tetrahedron pmid:5346199
Milne GW and Cohen LA The nuclear magnetic resonance and mass spectra of derivatives of cycloserine. 1967 Tetrahedron pmid:6037292
Korotaev GA and Tatarinova NV [Cycloserine content of the blood serum and its urinary excretion in tuberculosis]. 1972 Ter. Arkh. pmid:5039707
BaÄ­l'dinova IM [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis]. 1971 Ter. Arkh. pmid:5574526
UTKIN VV [Cycloserine in the therapy of pulmonary tuberculosis]. 1963 Ter. Arkh. pmid:13995571
UTKIN VV [Effect of cycloserine on the serum transaminase activity in patients with tuberculosis]. 1961 Ter. Arkh. pmid:13779418